(Press-News.org) Every year, over 15,500 Australians are diagnosed with bowel cancer, and it is the second leading cause of cancer deaths in the country. Over 1,700 (one in ten) of those diagnosed are young Australians aged under 50, and this incidence is increasing.
There is an urgent need to discover more effective treatments and improve bowel cancer screening, particularly for early-onset bowel cancer (those aged 25-49 years). Australians born in 1990 onwards have double the risk of developing bowel cancer compared with those born in 1950. These younger bowel cancer patients often have poorer outcomes as they typically present with late-stage disease.
Immunotherapy is one of the most promising new treatments for cancer, which involves boosting the ability of immune cells to recognize and remove cancer cells. However, less than 10% of bowel cancer patients respond to current immunotherapies.
The results of a new study published on 6th October, 2023 (U.S ET), in the prestigious journal, Science Immunology, was led by researchers at the Olivia Newton-John Cancer Research Institute. Principal Investigator and Head of the Mucosal Immunity and Cancer Laboratory at the Olivia Newton-John Cancer Research Institute, Dr Lisa Mielke, explained the importance of this research breakthrough.
“We have discovered that an important group of immune cells in the large bowel - gamma delta T cells - are crucial to preventing bowel cancer.”
“Gamma delta T cells act as our frontline defenders in the bowel. What makes these immune cells extraordinary is that they constantly patrol and safeguard the epithelial cells lining the bowel, acting as warriors against potential cancer threats,” said Dr Mielke.
“When we analysed bowel cancer patient samples, we found that when more gamma delta T cells were present in the tumours, these patients were reported to have better outcomes and improved survival.”
The large bowel contains trillions of bacteria, viruses and fungi, collectively known as the microbiome. While some bacteria are associated with disease, others are extremely important for the immune system.
Lead co-author of this study, Marina Yakou, PhD candidate at the Olivia Newton-John Cancer Research Institute, described how this new research may lead to improved treatments for cancer patients in the future.
“We discovered that the amount, and diversity of, the microbiome in the large bowel resulted in a higher concentration of a molecule called TCF-1 on Gamma delta T cells compared to other areas of the gut. This molecule (TCF-1) suppresses our natural immune response, the gamma delta T cells, from fighting off bowel cancer.”
“When we deleted TCF-1 in gamma delta T cells using pre-clinical models, this fundamentally changed the behaviour of these immune cells and we saw a remarkable reduction in the size of bowel cancer tumours,” said Ms Yakou.
“Our world-first research breakthrough paves a new roadmap for developing targeted combination immunotherapies to more effectively treat bowel cancer patients.”
This research discovery also opens up new possibilities for understanding how the microbiome and immune cells in the bowel interact, which could lead to the development of new strategies to lower bowel cancer risk and better screen for bowel cancer.
This is promising news for 36-year-old bowel cancer patient, Elise Stapleton, who was initially diagnosed with reoccurring Endometriosis. However, in January this year, she received a shock diagnosis of Stage 3 bowel cancer.
“After waking up from my surgery to remove endometriosis, the bombshell hit. Instead of a planned keyhole surgery, surgeons told me that they had found a tumour and performed open surgery to remove ‘what they could’. I then had a second operation to remove 20-25cms of my large bowel, follow up chemotherapy in April; and I have side-effects from the surgery and treatment.”
“My life has changed dramatically. After having been through a lot in a very short amount of time this year, I’m now feeling very empowered. I want to help raise awareness with young people that bowel cancer is not just an older person’s disease and to trust your instincts – if something doesn’t seem right, then keep following it up with health professionals,” explained Elise.
“I’m hopeful that this new research may lead to more targeted immunotherapies that will result in less side effects, and hopefully even one day help to design better screening so people can be more accurately diagnosed and treated earlier.”
This research study was made possible with thanks to funding from the National Health and Medical Research Council (NHMRC), Victorian Government acting through the Victorian Cancer Agency, Priority Driven Young Investigator Grant from Cure Cancer Australia Foundation, and a career recovery grant from Veski.
END
World-first research breakthrough sparks new hope for bowel cancer patients
Researchers at Olivia Newton-John Cancer Research Institute discover a new roadmap to beating bowel cancer
2023-10-06
ELSE PRESS RELEASES FROM THIS DATE:
3D genome architecture influences SCID-X1 gene therapy success
2023-10-06
Patients with X-linked severe combined immunodeficiency disorder (SCID-X1), sometimes called “bubble boy disease,” are born with a defective gene that prevents them from producing immune cells. Gene therapy from St. Jude Children’s Research Hospital restored the immune system in multiple infants with SCID-X1 in 2019 by supplying copies of the corrected gene. Through ongoing efforts to monitor patient safety, St. Jude scientists recently documented where the gene copies integrate into patient DNA, providing a foundation to understand the biology and safety of using lentiviral vectors. The findings were published today in Science Advances.
“We ...
Human brain seems impossible to map. What if we started with mice?
2023-10-06
The human brain is a tangled highway of wires emanating from nearly 100 billion neurons, all of which communicate across trillions of junctions called synapses. “Depressingly complex,” Harvard neuroscientist Jeff Lichtman calls it. The only way to understand this highway, says Lichtman, is to create a map.
Lichtman, the Jeremy R. Knowles Professor of Molecular and Cellular Biology, has spent several decades generating such maps, and in doing so has pioneered a field known as “connectomics.” ...
Study validates pyrvinium as treatment to prevent stomach cancer
2023-10-06
A study published Oct. 4 in Gastroenterology further validates that pyrvinium, a drug that has been used for decades for intestinal pinworms, can be repurposed as a preventative treatment for stomach cancer.
Eunyoung Choi, PhD, assistant professor of Surgery, and colleagues have demonstrated in human organoids and mouse models that the drug induces cell death in precancerous lesions. Pyrvinium blockades both the MEK/ERK and STAT3 signaling pathways. In another study she led, which was published last year in Gastroenterology, the researchers demonstrated that pyrvinium blocked regeneration of dysplastic ...
Researchers catch protons in the act of dissociation with SLAC’s ultrafast 'electron camera'
2023-10-06
Scientists have caught fast-moving hydrogen atoms – the keys to countless biological and chemical reactions – in action.
A team led by researchers at the Department of Energy’s SLAC National Accelerator Laboratory and Stanford University used ultrafast electron diffraction (UED) to record the motion of hydrogen atoms within ammonia molecules. Others had theorized they could track hydrogen atoms with electron diffraction, but until now nobody had done the experiment successfully.
The results, published October 5 in Physical ...
Scientists investigate Grand Canyon's ancient past to predict future climate impacts
2023-10-06
The Grand Canyon’s valleys and millions of years of rock layers spanning Earth’s history have earned it a designation as one of the Seven Natural Wonders of the World. But, according to a new UNLV and University of New Mexico study, its marvels extend to vast cave systems that lie beneath the surface, which just might hold clues to better understand the future of climate change — by studying nature’s past.
A research team led by UNLV paleoclimatologist and Professor Matthew Lachniet that included the University of New Mexico Department of Earth & Planetary Sciences Distinguished Professor Yemane Asmerom and Research Scientist Victor Polyak and other ...
ESMO Congress 2023
2023-10-06
Lugano, Switzerland, 6 October 2023 – Under the promise to “Disseminating innovative research for optimal cancer care” as this year’s tagline reads, the ESMO Congress 2023 will be held in Madrid between 20-24 October 2023 with a virtual component to allow as many people as possible to attend.
From a keynote lecture pinpointing the hallmarks of cancer in the current year through the reinforced commitment towards more academic input in the drug development process for better cancer care, and then further down to the dramatic scenarios brought by the too many situations of crisis in the world which have an unbearable impact ...
ORNL, University of Texas Rio Grande Valley partner to provide students research, mentorship opportunities
2023-10-06
The Department of Energy’s Oak Ridge National Laboratory and the University of Texas Rio Grande Valley, known as UTRGV, have signed a memorandum of understanding to strengthen research cooperation and establish a collaborative program for undergraduate research and education, further cementing relationships and collaboration between the lab and minority-serving institutions. This partnership builds a pathway for students to pursue science, technology, engineering and mathematics, or STEM, careers through DOE by complementing ...
Lurbinectedin for Neuroendocrine Tumors (NETs)
2023-10-06
“Several ongoing trials hope to further elucidate the role of lurbinectedin in highgrade neuroendocrine neoplasms [...]”
BUFFALO, NY- October 6, 2023 – A new editorial paper was published in Oncoscience (Volume 10) on June 14, 2023, entitled, “Lurbinectedin, a DNA minor groove inhibitor for neuroendocrine neoplasms beyond small cell lung cancer.”
In their new editorial, researchers Deepak Bhamidipati and Vivek Subbiah from the Sarah Cannon Research Institute discuss lurbinectedin as a method to treat neuroendocrine tumors (NETs). NETs encompass a variety ...
Clinical trial reveals benefits of inhaled nitric oxide for patients with respiratory failure due to COVID-19 pneumonia
2023-10-06
Key Takeaways
Researchers have posted the results of a multisystem phase II clinical trial of patients with COVID-19 and respiratory failure
Patients who received inhaled nitric oxide had improved blood oxygen levels and fewer risks of long-term sensory and motor neurologic symptoms
They also experienced a faster reduction of viral load in sputum and blood
BOSTON – Inhaled nitric oxide gas widens blood vessels in the lungs and is used to treat severe cardio-pulmonary conditions in newborns and adults.
A recent multicenter international ...
nTIDE September 2023 Jobs Report: Employment trend holds steady at historic highs through early autumn for people with disabilities
2023-10-06
East Hanover, NJ – October 6, 2023 –The labor force participation and employment-to-population ratio have held relatively steady throughout the summer and into the fall for people with disabilities, while percentages for people without disabilities may have maxed out at their pre-pandemic baseline, according to today’s National Trends in Disability Employment – semi-monthly update (nTIDE), issued by Kessler Foundation and the University of New Hampshire’s Institute on Disability (UNH-IOD). In comparison, the employment-to-population ratio for people without disabilities remained flat with no change, while ...
LAST 30 PRESS RELEASES:
Reality check: making indoor smartphone-based augmented reality work
Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain
Black men — including transit workers — are targets for aggression on public transportation, study shows
Troubling spike in severe pregnancy-related complications for all ages in Illinois
Alcohol use identified by UTHealth Houston researchers as most common predictor of escalated cannabis vaping among youths in Texas
Need a landing pad for helicopter parenting? Frame tasks as learning
New MUSC Hollings Cancer Center research shows how Golgi stress affects T-cells' tumor-fighting ability
#16to365: New resources for year-round activism to end gender-based violence and strengthen bodily autonomy for all
Earliest fish-trapping facility in Central America discovered in Maya lowlands
São Paulo to host School on Disordered Systems
New insights into sleep uncover key mechanisms related to cognitive function
USC announces strategic collaboration with Autobahn Labs to accelerate drug discovery
Detroit health professionals urge the community to act and address the dangers of antimicrobial resistance
3D-printing advance mitigates three defects simultaneously for failure-free metal parts
Ancient hot water on Mars points to habitable past: Curtin study
In Patagonia, more snow could protect glaciers from melt — but only if we curb greenhouse gas emissions soon
Simplicity is key to understanding and achieving goals
Caste differentiation in ants
Nutrition that aligns with guidelines during pregnancy may be associated with better infant growth outcomes, NIH study finds
New technology points to unexpected uses for snoRNA
Racial and ethnic variation in survival in early-onset colorectal cancer
Disparities by race and urbanicity in online health care facility reviews
Exploring factors affecting workers' acquisition of exercise habits using machine learning approaches
Nano-patterned copper oxide sensor for ultra-low hydrogen detection
Maintaining bridge safer; Digital sensing-based monitoring system
A novel approach for the composition design of high-entropy fluorite oxides with low thermal conductivity
A groundbreaking new approach to treating chronic abdominal pain
ECOG-ACRIN appoints seven researchers to scientific committee leadership positions
New model of neuronal circuit provides insight on eye movement
Cooking up a breakthrough: Penn engineers refine lipid nanoparticles for better mRNA therapies
[Press-News.org] World-first research breakthrough sparks new hope for bowel cancer patientsResearchers at Olivia Newton-John Cancer Research Institute discover a new roadmap to beating bowel cancer